| Karen Bowman, | |
|
1801 Chukka Hina, Durant, OK 74701-7117 | |
| (580) 920-2100 | |
| Not Available |
| Full Name | Karen Bowman |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Infection Control |
| Location | 1801 Chukka Hina, Durant, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861139784 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WI0600X | Registered Nurse - Infection Control | R0070068 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Bowman, 671 Island Bayou Dr, Calera, OK 74730-3857 Ph: (580) 775-7191 | Karen Bowman, 1801 Chukka Hina, Durant, OK 74701-7117 Ph: (580) 920-2100 |
News Archive
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer, today announced the pricing of its initial public offering of 14,300,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions. All of the shares in the offering are being sold by Merrimack.
Researchers based at the Centers for Disease Control and Prevention (CDC) found that many primary care doctors would bring women back for cancer screening annually - while recommendations generally call for a three-year wait after normal tests. This translates to higher costs to women and the healthcare system, as well as a risk of unnecessary treatment for false-positive test results - with very little additional cancer-catching benefit say experts. Lead author Katherine Roland said, "There's really no advantage to annual screening compared to screening every two or three years."
A new data analysis tool developed by researchers at The University of Texas MD Anderson Cancer Center incorporates a user-friendly, natural-language interface to allow biomedical researchers without specialized expertise in bioinformatics or programming languages to conduct intuitive analysis of large datasets.
Cells with stem-cell characteristics appear to be especially important in the formation and metastasis of tumors. Scientists have now developed a universal fluorescent probe for these "cancer stem cells". As reported in the journal Angewandte Chemie, this dye also selectively kills off the cells.
› Verified 1 days ago
Ms. Angela Renee Wright, ARNP-CNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 702 Bryan Dr Ste 100, Durant, OK 74701 Phone: 580-924-4704 Fax: 580-924-6001 | |
April Ann Lehrling, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1413 North 4th Ave, Suite 229, Durant, OK 74701 Phone: 580-745-2988 Fax: 580-745-2243 | |
Dara Sha'ree Wesberry, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2010 W Locust St, Durant, OK 74701 Phone: 580-740-1441 | |
Carla White, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 134 N 12th Ave, Durant, OK 74701 Phone: 580-924-6363 Fax: 580-924-0379 | |
Mrs. Carol Lynn Kennedy, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2701 W University Blvd, Durant, OK 74701 Phone: 580-740-4053 Fax: 877-725-8976 | |
Mrs. Shyanne Roselynn Shipp, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1706 Delivery Ln, Durant, OK 74701 Phone: 580-745-5228 Fax: 580-920-9976 | |
Mrs. Kayla Marie Adams, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1801 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 |